NCT04127396 2021-07-23
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT
Beijing Ditan Hospital
Phase 4 Unknown
Clinical Trials
10 trialsNCT02504983 2020-02-05
Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma
Chang Gung Memorial Hospital
Phase 4 Unknown
NCT02961998 2019-09-10
Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail
Sun Yat-sen University
Phase 4 Completed
NCT01409499 2018-09-11
2011PTAHCC
Sun Yat-sen University
Phase 4 Completed
NCT03518502 2018-05-08
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
Korea University
Phase 4 Unknown
NCT03178656 2017-12-21
A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis
Huazhong University of Science and Technology
Phase 4 Unknown
NCT01849588 2017-04-19
HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)
Massachusetts General Hospital
Phase 4 Terminated
NCT01203787 2015-03-05
Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
University of Florida
Phase 4 Completed
NCT00352859 2014-12-30
Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Bayer
Phase 4 Terminated
NCT01098760 2013-10-31
HATT
Bayer
Phase 4 Completed